Laura De Castro
Clinical Director · UPMC Medical Education
Credentials: · · ·
History
- Present
- Present
Present
- 1989–1992
Hematology and Medical Oncology
- 1986–1989
Internal Medicine
- 1982–1986
Doctor of Medicine
Research
JAMA · 2003 · 690 citations
The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up
American Journal of Hematology · 2010 · 400 citations
Factors associated with survival in a contemporary adult sickle cell disease cohort
American Journal of Hematology · 2014 · 242 citations
18 papers
10 papers
10 papers
- EO
8 papers
- WS
8 papers
6 papers · 4 as a resident
6 papers
6 papers
Grants
- 2009–2013
Phase 11 Study of Propranolol as Anti-Adhesive Therapy in SCD
National Heart, Lung, and Blood Institute · K01
Contact PI · $395.9K · Duke University
- 2010–2012
Propranolol as Anti-Adhesive Therapy in Scd
National Heart, Lung, and Blood Institute · R21
PI · $416.2K · Duke University
- 2008–2011
Relationship of Depression to SCD Severity, Health Care Utilization and QoL
Agency for Healthcare Research and Quality · R21
Contact PI · $312.5K · Duke University
Clinical trials
- 2004–2008
Effectiveness of Arginine as a Treatment for Sickle Cell Anemia
Principal investigator · Completed · Phase 2
UCSF Benioff Children's Hospital Oakland
- 2005–2008
Priapism in Boys and Men With Sickle Cell Disease - Demographics, Characteristics and Prevalence
Study chair · Completed
University of Texas Southwestern Medical Center